Subject Matter Expert

Russ Somma, PhD
Russ's technical expertise helped a client achieve novel therapeutic product development and commercialization goals.
The company was recently acquired for $255 MM, culminating in a Development and License Agreement and a deferred Merger Agreement.
Drug Development and Tech Transfer
Whether the products are new or existing, our Drug Development and Technology Transfer services offer solutions that consistently maintain quality and compliance to effectively accelerate scale-up through market launch. Our experts provide ideas that speed pharmaceutical and biotech products to market.
Creating a sustainable edge requires innovation and the ability to bring innovation to market quickly. Partnering with our affiliate, SommaTech Consulting, we understand the critical interface between product development and market dominance. By harmonizing multiple scientific, manufacturing and business processes across the regulatory landscape, our Pharmaceutical Technology Solutions have helped our clients achieve clinical phase as well as commercial success while consistently meeting regulatory requirements.
Accelerating Scale-up through Market Launch
-
Product Development
-
Production Troubleshooting
-
Product Validation
-
Technology Transfer
|
-
Product Stability Programs
-
Cost Effective Products
-
Secure Supply Chain
-
Formulation Support
|
Expert Insight
-
"Embracing Quality by Design: Applying QbD Concepts can help CMOs Create Value", Russ Somma, PhD and Andrew A. Signore, PE, PMP-DBIA, CPIP, Contract Pharma, October 2008
-
"No More Approvable Letters: An Expert's Take", Russ Somma, PhD, PharmExec Blog, Published July 16, 2008
-
"Development Knowledge can Increase Manufacturing Capability and Facilitate Quality by Design", Russ Somma PhD, Journal of Pharmaceutical Innovation, December 2007
-
"Using Technology Transfer to Maximize Business Efficiency", Russ Somma, PhD, Pharmaceutical Engineering, September/October, 2007
-
"A Technology Viewpoint: Aspects of Non-Invasive Drug Therapy", Russ Somma, PhD, LifeSciTech, Q3 2007
|